| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 28, 2014
MINNEAPOLIS - October 28, 2014 - Medtronic, Inc. (NYSE: MDT) today announced it has initiated the PERIGON (PERIcardial SurGical AOrtic Valve ReplacemeNt) Pivotal Trial, a global, prospective...
-
Oct 27, 2014Covidien Launches Next-Generation SuperDimension™ Lung Navigation Software to Simplify Planning, Enhance Visualization During a Procedure
DUBLIN--(BUSINESS WIRE)--Oct. 27, 2014-- Further underscoring its ongoing commitment to lung health, Covidien (NYSE:COV) today unveiled a next-generation version of its superDimension™...
-
Oct 23, 2014Lung cancer is the number one cancer killer of women
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 23, 2014-- Covidien (NYSE: COV) is joining forces with the American Lung Association’s LUNG FORCE movement to raise awareness of the threat that lung...
-
Oct 21, 2014System Offers New Approach to Single-Level ACDF Procedures
MEMPHIS, TENN. - October 21, 2014 - Medtronic, Inc. (NYSE: MDT) announced the U.S. launch of the DIVERGENCE(TM) Anterior Cervical Fusion System for the treatment of single-level cervical disc...
-
Oct 21, 2014Covidien-World Stroke Organization Survey Shows Low Knowledge of Stroke Prevention, Treatment Options
Dublin, Ireland and Geneva – Oct. 22, 2014 – Despite its being the second leading cause of death worldwide, many people still do not recognize the threat stroke poses and the warning signs...
-
Oct 20, 2014
MEMPHIS, TENN., - October 20, 2014 - Medtronic, Inc. (NYSE: MDT) introduced its Pure Titanium Coating (PTC) platform of interbody fusion devices for the spine today at the 2014 Congress of...
-
Oct 17, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 17, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against...
-
Oct 15, 2014
HeartWare International, Inc. (NASDAQ: HTWR) has scheduled a conference call to discuss its financial results for the three months ended September 30, 2014, at 8:00 a.m. U.S. Eastern Daylight Time...
-
Oct 14, 2014In-Clinic Study Marks Critical Step Toward an Artificial Pancreas and Key Milestone Toward U.S. Commercialization
MINNEAPOLIS - October 14, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its breakthrough...
-
Oct 13, 2014Late-Breaking ADVANCE Direct Aortic Study Presented at EACTS Reaffirms CoreValve System's Positive Performance with Low Mortality and Stroke
MINNEAPOLIS and MILAN - Oct. 13, 2014 -Medtronic, Inc. (NYSE: MDT) today announced positive data from nine European centers in a study of the direct aortic approach (through the upper chest) with...
-
Oct 13, 2014Covidien Promotes Greater Global Awareness of Thrombosis Risks
October 13, 2014 12:01 AM Eastern Daylight Time DUBLIN, Ireland--(BUSINESS WIRE)--As part of a global effort to highlight the threat posed by venous thromboembolism (VTE), Covidien plc today...
-
Oct 10, 2014
Dublin, Ireland -- October 10, 2014 – Covidien today announced that it has notified customers of a voluntary Field Safety Alert for certain Medi-Trace™ Cadence and Kendall™ Multi-function...
-
Oct 10, 2014
MINNEAPOLIS -- October 10, 2014 -- Medtronic (NYSE: MDT) today announced the executive team who will lead the combined organization following the close of its proposed acquisition of Covidien. The...
-
Oct 10, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 10, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Oct 9, 2014Monitor is only portable oximeter on the market that is indicated for use in home care settings and is compliant with international standards for devices used in the home health care environment
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 9, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the Nellcor™ Portable SpO2 Patient Monitoring...
-
Oct 8, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 8, 2014-- Covidien plc: FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
-
Oct 7, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 7, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Oct 7, 2014FDA-Approved System Provides Patients with Added Benefits While Testing Innovative Therapy for Bladder and Bowel Incontinence
MINNEAPOLIS - October 7, 2014 - After living with overactive bladder and urinary retention symptoms for 11 years, Jennifer LaForest, a 26-year-old woman from Auburn Hills, Michigan, recently...
-
Oct 3, 2014Company reaffirms commitment to Covidien transaction
MINNEAPOLIS -October 3, 2014- Medtronic, Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, today announced that it intends to use approximately $16 billion in...
-
Sep 30, 2014Despite prevalence of PAD symptoms, the majority of patients have not consulted a physician
DUBLIN, Ireland, Sep 30, 2014 (BUSINESS WIRE) --More than 40 percent of Americans aged 40 and older have experienced one or more of the most common symptomsi of peripheral arterial disease (PAD)....
-
Sep 29, 2014Building on Nearly a Decade of Growth, Partnership Allows Twin Cities In Motion to Continue to Expand and Enhance Race Events and Youth Programming
MINNEAPOLIS - Sept. 29, 2014 -Medtronic and Twin Cities In Motion, the organizers of the Medtronic Twin Cities Marathon, today announced a five-year, $2.5 million agreement that will keep...
-
Sep 25, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 25, 2014-- Covidien plc (NYSE: COV) will report fourth-quarter and fiscal 2014 results on November 5. The company will host a conference call for investors...
-
Sep 25, 2014$6 Million Marks the Largest Private-Sector Contribution to Date to Address One of the World's Most Neglected, Yet Preventable, Diseases Affecting the World's Poor
MINNEAPOLIS - September 25, 2014 - Medtronic today announced a five-year, $6 million (USD) funding commitment from Medtronic Philanthropy to reduce premature mortality resulting from Rheumatic...
-
Sep 24, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 24, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Sep 21, 2014
MINNEAPOLIS - Sept. 22, 2014 - Medtronic, Inc. (NYSE: MDT) has received CE (Conformité Européenne) Mark for the TYRX(TM) Absorbable Antibacterial Envelope. This innovative mesh envelope covers...